Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli

Clinical and Vaccine Immunology

Volumn 17, Issue 12, 2010, Pages 1903-1908

  Tang, Yan ^a,b   Wang, Li ^a   Zhang, Peiyin ^a   Wei, Hongfei ^a   Gao, Rui ^c   Liu, Xinming ^b   Yu, Yongli ^a   Wang, Liying ^a  

^a Basic Medical College   (China)

^b JILIN UNIVERSITY   (China)

^c Economic Information Center of Jilin Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MUCIN 1; MUCIN 1 ANTIBODY; PROTEIN 8R MUCPT; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGENICITY; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIRECT ENZYME LINKED IMMUNOSORBENT ASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TANDEM REPEAT;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMANS; MIDDLE AGED; MUCIN-1; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TANDEM REPEAT SEQUENCES; TUMOR MARKERS, BIOLOGICAL;

EID: 78649853469     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00142-10     Document Type: Article

References (29)

1. Braun, D. P., K. A. Crist, F. Shaheen, E. D. Staren, S. Andrews, and J. Parker. 2005. Aromatase inhibitors increase the sensitivity of human tumor cells to monocyte-mediated, antibody-dependent cellular cytotoxicity. Am. J. Surg. 190:570-571.
2. Croce, M. V., M. Isla-Larrain, A. Capafons, M. R. Price, and A. Segal-Eiras. 2001. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women. Breast Cancer Res. Tr. 69:1-11.
3. Croce, M. V., M. T. Isla-Larrain, M. R. Price, and A. Segal-Eiras. 2001. Detection of circulating mammary mucin (Muc1) and MUC1 immune complexes (Muc1-CIC) in healthy women. Int. J. Biol. Markers 16:112-120.
4. Croce, M. V., M. T. Isla-Larrain, S. O. Demichelis, J. R. Gori, M. R. Price, and A. Segal-Eiras. 2003. Tissue and serum MUC1 mucin detection in breast cancer patients. Breast Cancer Res. Treat. 81:195-207.
5. Ebeling, F. G., P. Stieber, M. Untch, D. Nagel, G. E. Konecny, U. M. Schmitt, A. Fateh-Moghadam, and D. Seidel. 2002. Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. Br. J. Cancer 86:1217-1222.
6. Gulley, J. L., P. M. Arlen, K. Y. Tsang, J. Yokokawa, C. Palena, D. J. Poole, C. Remondo, V. Cereda, J. L. Jones, M. P. Pazdur, J. P. Higgins, J. W. Hodge, S. M. Steinberg, H. Kotz, W. L. Dahut, and J. Schlom. 2008. Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin. Cancer Res. 14:3060-3069.
7. Hamanaka, Y., Y. Suehiro, M. Fukui, K. Shikichi, K. Imai, and Y. Hinoda. 2003. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. Int. J. Cancer 103:97-100.
8. Heuser, C., M. Ganser, A. Hombach, H. Brand, G. Denton, F. G. Hanisch, and H. Abken. 2003. An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells. Br. J. Cancer 89:1130-1139.
9. Hinoda, Y., N. Nakagawa, H. Nakamura, Y. Makiguchi, F. Itoh, M. Adachi, T. Yabana, K. Imai, and A. Yachi. 1993. Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis. Immunol. Lett. 35:163-168.
10. Hirasawa, Y., N. Kohno, A. Yokoyama, K. Kondo, K. Hiwada, and M. Miyake. 2000. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer. Am. J. Respir. Crit. Care. Med. 161:589-594.
11. Klee, G. G., and W. E. Schreiber. 2004. MUC1 gene-derived glycoprotein assays for monitoring breast cancer (CA 15-3, CA 27.29, BR): are they measuring the same antigen? Arch. Pathol. Lab. Med. 128:1131-1135.
12. Kokko, R., K. Holli, and M. Hakama. 2002. CA 15-3 in the follow-up of localized breast cancer: a prospective study. Eur. J. Cancer 38:1189-1193.
13. Kotera, Y., J. Darrell Fontenot, G. Pecher, R. S. Metzgar, and O. J. Finn. 1994. Humoral immunity against a tandem repeat epitope of human mucin MUC1 in sera from breast pancreatic and colon cancer patients. Cancer Res. 54:2856-2860.
14. Li, D. P., H. Li, P. Y. Zhang, X. L. Wu, H. F. Wei, L. Wang, M. Wan, P. Deng, Y. Zhang, and L. J. Wang. 2006. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity. Eur. J. Immunol. 36:1324-1336.
15. Mann, K. 1990. Tumor markers in testicular cancer. Urologe A 29:77-86. (In German.)
16. Nakamura, H., Y. Hinoda, N. Nakagawa, Y. Makiguchi, F. Itoh, T. Endo, and K. Imai. 1998. Detection of circulating anti-MUC1 mucin core protein antibodies in patients with colorectal cancer. J. Gastroenterol. 33:354-361.
17. Rabassa, M. E., M. V. Croce, A. Pereyra, and A. Segal-Eiras. 2006. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis. BMC. Cancer 6:253.
18. Rakha, E. A., R. W. Boyce, D. Abd El-Rehim, T. Kurien, A. R. Green, E. C. Paish, J. F. Robertson, and I. O. Ellis. 2005. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) and their prognostic significance in human breast cancer. Mod. Pathol. 18:1295-1304.
19. Ramlau, R., E. Quoix, J. Rolski, M. Pless, H. Lena, E. Lévy, M. Krzakowski, D. Hess, E. Tartour, M. P. Chenard, J. M. Limacher, N. Bizouarne, B. Acres, C. Halluard, and T. Velu. 2008. A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV non-small cell lung cancer. J. Thorac. Oncol. 3:735-744.
20. Richards, E.R., P. L. Devine, R. J. Quin, J. D. Fontenot, B. G. Ward, and M. A. McGuckin. 1998. Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women. Cancer Immunol. Immunother. 46:245-252.
21. Tang, Y., H. Li, P. Y. Zhang, D. P. Li, Y. M. Wang, H. F. Wei, A. L. Wang, Y. L. Yu, and L. Y. Wang. 2005. Prokaryotic expression and purification of 8R-MUC1 core peptides fusion protein. J. Jilin Univ. 31:21-24.
22. Taylor-Papadimitriou, J., J. M. Burchell, T. Plunkett, R. Graham, I. Correa, D. Miles, and M. Smith. 2002. MUC1 and the immunobiology of cancer. J. Mamm. Gland Biol. Neoplasia 7:209-221.
23. Treon, S. P., P. Maimonis, D. Bua, G. Young, N. Raje, J. Mollick, D. Chauhan, Y. T. Tai, T. Hideshima, Y. Shima, J. Hilgers, S. von Mensdorff-Pouilly, A. R. Belch, L. M. Pilarski, and K. C. Anderson. 2000. Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma. Blood 96:3147-3153.
24. Varela, J. C., C. Atkinson, R. Woolson, T. E. Keane, and S. Tomlinson. 2008. Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection. Int. J. Cancer 123:1357-1363.
25. von Mensdorff-Pouilly, S., A. A. Verstraeten, P. Kenemans, F. G. Snijdewint, A. Kok, G. J. Van Kamp, M. A. Paul, P. J. Van Diest, S. Meijer, and J. Hilgers. 2000. Survival in early breast cancer patients is favorably influenced by a humoral immune response to polymorphic epithelial mucin. J. Clin. Oncol. 18:574-583.
26. von Mensdorff-Pouilly, S., M. M. Gouretvich, P. Kenemans, A. A. Verstraeten, S. V. Litvinov, G. J. van Kamp, S. Meijer, J. Vermorken, and J. Hilgers. 1996. Humoral immune response to polymorphic epithelial mucin (MUC1) in patients with benign and malignant breast tumors. Eur. J. Cancer 32:1325-1331.
27. von Mensdorff-Pouilly, S., M. M. Gourevitch, P. Kenemans, A. A. Verstraeten, G. J. van Kamp, A. Kok, K. van Uffelen, F. G. Snijdewint, M. A. Paul, and S. Meijer. 1998. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1). Tumour Biol. 19:186-195.
28. Yamamoto, M., A. Bharti, Y. Li, and D. Kufe. 1997. Interaction of the DF3/MUC1 breast carcinoma associated antigen and β-catenin in cell adhesion. J. Biol. Chem. 272:12492-12494.
29. Yang, E., X. F. Hu, and P. X. Xing. 2007. Advances of MUC1 as a target for breast cancer immunotherapy. Histol. Histopathol. 22:905-922.